177 related articles for article (PubMed ID: 27579613)
41. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
Fang WT; Feng J; Mao T; Fu SJ; Chen WH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
[TBL] [Abstract][Full Text] [Related]
42. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
[TBL] [Abstract][Full Text] [Related]
43. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
44. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
[TBL] [Abstract][Full Text] [Related]
45. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
Sun ZG; Wang Z
Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
[TBL] [Abstract][Full Text] [Related]
46. Predicting lymph node metastasis for endoscopic resection of superficial esophageal squamous cell carcinoma.
Ma DW; Jung DH; Kim JH; Park JJ; Youn YH; Park H
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):397-402.e1. PubMed ID: 30143376
[TBL] [Abstract][Full Text] [Related]
47. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.
Wang L; Wang C; Wang J; Huang X; Cheng Y
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2077-2086. PubMed ID: 28601935
[TBL] [Abstract][Full Text] [Related]
48. Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma.
Huang Q; Luo K; Chen C; Wang G; Jin J; Kong M; Li B; Liu Q; Li J; Rong T; Chen H; Zhang L; Chen Y; Zhu C; Zheng B; Wen J; Zheng Y; Tan Z; Xie X; Yang H; Fu J
J Thorac Oncol; 2016 Apr; 11(4):583-92. PubMed ID: 26792626
[TBL] [Abstract][Full Text] [Related]
49. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.
Lu JC; Tao H; Chen ZZ; Qian PD
Dis Esophagus; 2009; 22(6):490-5. PubMed ID: 19191849
[TBL] [Abstract][Full Text] [Related]
51. [Relationship of gross tumor volume with lymph node metastasis and prognosis of esophageal carcinoma].
Xu Q; Liu ZK; Cao YK; Li YM; Zhu SC
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):684-7. PubMed ID: 23159082
[TBL] [Abstract][Full Text] [Related]
52. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
[TBL] [Abstract][Full Text] [Related]
53. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
[TBL] [Abstract][Full Text] [Related]
55. A novel multivariate scoring system for determining the prognosis of lymph node-negative esophageal squamous cell carcinoma following surgical therapy: an observational study.
Ma G; Zhang X; Ma Q; Rong T; Long H; Lin P; Fu J; Zhang L
Eur J Surg Oncol; 2015 Apr; 41(4):541-7. PubMed ID: 25659876
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma.
Zheng YZ; Dai SQ; Li W; Cao X; Li Y; Zhang LJ; Fu JH; Wang JY
World J Gastroenterol; 2013 May; 19(18):2811-7. PubMed ID: 23687419
[TBL] [Abstract][Full Text] [Related]
57. Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis.
Geng Y; Shao Y; Zhu D; Zheng X; Zhou Q; Zhou W; Ni X; Wu C; Jiang J
Sci Rep; 2016 Dec; 6():39482. PubMed ID: 28000729
[TBL] [Abstract][Full Text] [Related]
58. A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy.
Zhang F; Han H; Wang C; Wang J; Zhang G; Cao F; Cheng Y
World J Surg Oncol; 2013 Oct; 11():249. PubMed ID: 24083572
[TBL] [Abstract][Full Text] [Related]
59. Impact of tumor length on survival for patients with resected esophageal cancer.
Mirinezhad SK; Jangjoo AG; Seyednejad F; Naseri AR; Mohammadzadeh M; Nasiri B; Eftekharsadat AT; Farhang S; Somi MH
Asian Pac J Cancer Prev; 2014; 15(2):691-4. PubMed ID: 24568480
[TBL] [Abstract][Full Text] [Related]
60. New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma.
Lee GD; Lee SE; Kim KM; Kim YH; Ahn JH; Jung S; Choi YL; Kim HR; Park SI; Shim YM
Ann Surg; 2015 Dec; 262(6):965-71. PubMed ID: 26501489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
